Arthritis Today - Spring 2006
Issue 132
Childhood arthritis – arc to encourage new research among young clinicians
A new fellowship scheme to encourage research into childhood arthritis has been set up by arc in memory of the celebrated paediatric rheumatologist Dr Barbara Ansell, who died in 2001.
Lost in translation? Not in Glasgow
Translational research continues apace in Glasgow, aided by ongoing arc funding of £1.5m. Jane Tadman reports.
Spotlight on science
Dr Graham Riley and Dr Elspeth Wise explain their work in an ongoing series of articles in which arc -funded researchers explain their work.
Arthritis in the future
Where will arthritis research and treatment be in ten years' time? In the first of a new five-part series Arthritis Today asks arc-funded osteoarthritis experts, a clinician and two scientists, to look into their crystal balls. The result is two very contrasting views.
Glucosamine - Supplementary evidence
Glucosamine is a popular supplement widely taken for osteoarthritis. But does it work? Dr Kate McLintock, a recently qualified GP and national winner of the arc GP Registrar Prize, takes a look at the evidence.
Statins – the new “wonder drugs?”
Suddenly statins are everywhere. Now it seems that they can also help reduce cardiovascular risk in rheumatoid arthritis patients, and a major new arc trial aims to shed more light on these effects. Jane Tadman reports on the latest so-called wonder drugs.
Shouldering the pain
Professor Elaine Hay examines this common, painful, and little understood condition.
